1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered.
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2.
Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3.
Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. Voice of Customer
5.
Whole Genome
Sequencing Market Outlook.
5.1. Market Size & Forecast
5.1.1.
By Value
5.2. Market Share & Forecast
5.2.1.
By Sequencing Type (Large Whole-Genome Sequencing and
Small Genome Sequencing)
5.2.2.
By Product Type (Instrument, Kits, and Service)
5.2.3.
By Application (Diagnostics, Drug Discovery and
Development, Personalized Medicine, and Others)
5.2.4.
By End User (Hospitals and Clinics, Pharmaceutical and
Biotechnology Companies, and Others)
5.2.5.
By Company (2022)
5.2.6. By
Region
5.3. Product Market Map
6.
Asia-Pacific Whole
Genome Sequencing Market Outlook
6.1. Market Size & Forecast
6.1.1.
By Value
6.2. Market Share & Forecast
6.2.1.
Sequencing Type
6.2.2.
Product Type
6.2.3.
Application
6.2.4.
End User
6.2.5.
By Country
6.3. Asia-Pacific: Country Analysis
6.3.1.
China Whole Genome
Sequencing Market Outlook.
6.3.1.1.
Market Size & Forecast
6.3.1.1.1.
By Value
6.3.1.2.
Market Share & Forecast
6.3.1.2.1.
Sequencing Type
6.3.1.2.2.
Product Type
6.3.1.2.3.
Application
6.3.1.2.4.
End User
6.3.2.
India Whole Genome
Sequencing Market Outlook.
6.3.2.1.
Market Size & Forecast
6.3.2.1.1.
By Value
6.3.2.2.
Market Share & Forecast
6.3.2.2.1.
Sequencing Type
6.3.2.2.2.
Product Type
6.3.2.2.3.
Application
6.3.2.2.4.
End User
6.3.3.
South Korea Whole
Genome Sequencing Market Outlook
6.3.3.1.
Market Size & Forecast
6.3.3.1.1.
By Value
6.3.3.2.
Market Share & Forecast
6.3.3.2.1.
Sequencing Type
6.3.3.2.2.
Product Type
6.3.3.2.3.
Application
6.3.3.2.4.
End User
6.3.4.
Japan Whole Genome
Sequencing Market Outlook
6.3.4.1.
Market Size & Forecast
6.3.4.1.1.
By Value
6.3.4.2.
Market Share & Forecast
6.3.4.2.1.
Sequencing Type
6.3.4.2.2.
Product Type
6.3.4.2.3.
Application
6.3.4.2.4.
End User
6.3.5.
Australia Whole
Genome Sequencing Market Outlook
6.3.5.1.
Market Size & Forecast
6.3.5.1.1.
By Value
6.3.5.2.
Market Share & Forecast
6.3.5.2.1.
Sequencing Type
6.3.5.2.2.
Product Type
6.3.5.2.3.
Application
6.3.5.2.4.
End User
7.
Europe Whole Genome
Sequencing Market Outlook
7.1. Market Size & Forecast
7.1.1.
By Value
7.2. Market Share & Forecast
7.2.1.
Sequencing Type
7.2.2.
Product Type
7.2.3.
Application
7.2.4.
End User
7.2.5.
By Country
7.3. Europe: Country Analysis
7.3.1.
France Whole Genome
Sequencing Market Outlook
7.3.1.1.
Market Size & Forecast
7.3.1.1.1.
By Value
7.3.1.2.
Market Share & Forecast
7.3.1.2.1.
Sequencing Type
7.3.1.2.2.
Product Type
7.3.1.2.3.
Application
7.3.1.2.4.
End User
7.3.2.
Germany Whole Genome
Sequencing Market Outlook
7.3.2.1.
Market Size & Forecast
7.3.2.1.1.
By Value
7.3.2.2.
Market Share & Forecast
7.3.2.2.1.
Sequencing Type
7.3.2.2.2.
Product Type
7.3.2.2.3.
Application
7.3.2.2.4.
End User
7.3.3.
United Kingdom Whole
Genome Sequencing Market Outlook
7.3.3.1.
Market Size & Forecast
7.3.3.1.1.
By Value
7.3.3.2.
Market Share & Forecast
7.3.3.2.1.
Sequencing Type
7.3.3.2.2.
Product Type
7.3.3.2.3.
Application
7.3.3.2.4.
End User
7.3.4.
Italy Whole Genome
Sequencing Market Outlook
7.3.4.1.
Market Size & Forecast
7.3.4.1.1.
By Value
7.3.4.2.
Market Share & Forecast
7.3.4.2.1.
Sequencing Type
7.3.4.2.2.
Product Type
7.3.4.2.3.
Application
7.3.4.2.4.
End User
7.3.5.
Spain Whole Genome
Sequencing Market Outlook
7.3.5.1.
Market Size & Forecast
7.3.5.1.1.
By Value
7.3.5.2.
Market Share & Forecast
7.3.5.2.1.
Sequencing Type
7.3.5.2.2.
Product Type
7.3.5.2.3.
Application
7.3.5.2.4.
End User
7.3.6.
North America Humic-based
bio stimulants Market Outlook.
7.4. Market Size & Forecast
7.4.1.
By Value
7.5. Market Share & Forecast
7.5.1.
Sequencing Type
7.5.2.
Product Type
7.5.3.
Application
7.5.4.
End User
7.5.5.
By Country
7.6. North America: Country Analysis
7.6.1.
United States Whole
Genome Sequencing Market Outlook
7.6.1.1.
Market Size & Forecast
7.6.1.1.1.
By Value
7.6.1.2.
Market Share & Forecast
7.6.1.2.1.
Sequencing Type
7.6.1.2.2.
Product Type
7.6.1.2.3.
Application
7.6.1.2.4.
End User
7.6.2.
Mexico Whole Genome
Sequencing Market Outlook
7.6.2.1.
Market Size & Forecast
7.6.2.1.1.
By Value
7.6.2.2.
Market Share & Forecast
7.6.2.2.1.
Sequencing Type
7.6.2.2.2.
Product Type
7.6.2.2.3.
Application
7.6.2.2.4.
End User
7.6.3.
Canada Whole Genome
Sequencing Market Outlook
7.6.3.1.
Market Size & Forecast
7.6.3.1.1.
By Value
7.6.3.2.
Market Share & Forecast
7.6.3.2.1.
Sequencing Type
7.6.3.2.2.
Product Type
7.6.3.2.3.
Application
7.6.3.2.4.
End User
8.
South America Whole
Genome Sequencing Market Outlook
8.1. Market Size & Forecast
8.1.1.
By Value
8.2. Market Share & Forecast
8.2.1.
Sequencing Type
8.2.2.
Product Type
8.2.3.
Application
8.2.4.
End User
8.2.5.
By Country
8.3. South America: Country Analysis
8.3.1.
Brazil Whole Genome
Sequencing Market Outlook
8.3.1.1.
Market Size & Forecast
8.3.1.1.1.
By Value
8.3.1.2.
Market Share & Forecast
8.3.1.2.1.
Sequencing Type
8.3.1.2.2.
Product Type
8.3.1.2.3.
Application
8.3.1.2.4.
End User
8.3.2.
Argentina Whole
Genome Sequencing Market Outlook
8.3.2.1.
Market Size & Forecast
8.3.2.1.1.
By Value
8.3.2.2.
Market Share & Forecast
8.3.2.2.1.
Sequencing Type
8.3.2.2.2.
Product Type
8.3.2.2.3.
Application
8.3.2.2.4.
End User
8.3.3.
Colombia Whole
Genome Sequencing Market Outlook
8.3.3.1.
Market Size & Forecast
8.3.3.1.1.
By Value
8.3.3.2.
Market Share & Forecast
8.3.3.2.1.
Sequencing Type
8.3.3.2.2.
Product Type
8.3.3.2.3.
Application
8.3.3.2.4.
End User
9.
Middle East and
Africa Whole Genome Sequencing Market Outlook
9.1. Market Size & Forecast
9.1.1.
By Value
9.2. Market Share & Forecast
9.2.1.
Sequencing Type
9.2.2.
Product Type
9.2.3.
Application
9.2.4.
End User
9.2.5.
By Country
9.3. MEA: Country Analysis
9.3.1.
South Africa Whole
Genome Sequencing Market Outlook
9.3.1.1.
Market Size & Forecast
9.3.1.1.1.
By Value
9.3.1.2.
Market Share & Forecast
9.3.1.2.1.
Sequencing Type
9.3.1.2.2.
Product Type
9.3.1.2.3.
Application
9.3.1.2.4.
End User
9.3.2.
Saudi Arabia Whole
Genome Sequencing Market Outlook
9.3.2.1.
Market Size & Forecast
9.3.2.1.1.
By Value
9.3.2.2.
Market Share & Forecast
9.3.2.2.1.
Sequencing Type
9.3.2.2.2.
Product Type
9.3.2.2.3.
Application
9.3.2.2.4.
End User
9.3.3.
UAE Whole Genome
Sequencing Market Outlook
9.3.3.1.
Market Size & Forecast
9.3.3.1.1.
By Value
9.3.3.2.
Market Share & Forecast
9.3.3.2.1.
Sequencing Type
9.3.3.2.2.
Product Type
9.3.3.2.3.
Application
9.3.3.2.4.
End User
9.3.4.
Kuwait Whole Genome
Sequencing Market Outlook
9.3.4.1.
Market Size & Forecast
9.3.4.1.1.
By Value
9.3.4.2.
Market Share & Forecast
9.3.4.2.1.
Sequencing Type
9.3.4.2.2.
Product Type
9.3.4.2.3.
Application
9.3.4.2.4.
End User
10. Market Dynamics
10.1.
Drivers
10.2.
Challenges
11. Market Trends & Developments
11.1.
Recent Developments
11.2.
Mergers & Acquisitions
11.3.
Product Developments
12.
Competitive
Landscape
12.1.
Business Overview
12.2.
Company Snapshot
12.3.
Products &
Services
12.4.
Financials (In case
of listed companies)
12.5.
Recent Developments
12.6.
SWOT Analysis
12.6.1.
GE Healthcare, Inc.
12.6.2.
Illumina, Inc.
12.6.3.
QIAGEN N.V.
12.6.4.
Thermo Fisher Scientific
12.6.5.
Agilent Technologies
12.6.6.
10 x Genomics
12.6.7.
BGI
12.6.8.
Oxford Nanopore
12.6.9.
Nebula Genomics
12.6.10.
Veritas Genetics.
13. Strategic Recommendations